1
|
Sehaki C, Jullian N, Ayati F, Fernane F, Gontier E. A Review of Pistacia lentiscus Polyphenols: Chemical Diversity and Pharmacological Activities. PLANTS (BASEL, SWITZERLAND) 2023; 12:279. [PMID: 36678991 PMCID: PMC9866577 DOI: 10.3390/plants12020279] [Citation(s) in RCA: 8] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 11/29/2022] [Revised: 01/03/2023] [Accepted: 01/05/2023] [Indexed: 06/17/2023]
Abstract
Pistacia lentiscus (lentisk) is a plant species of the Anacardiaceae family. It is a medicinal plant that grows wild in the Mediterranean region. This review aims to update the existing knowledge regarding P. lentiscus polyphenols by consulting references dated from 1996 to 2022. The data are organized and analyzed as follows: (i) to show the chemical diversity of phenolic products from P. lentiscus; (ii) to summarize the variability in phenolic composition and quantity; this could be attributed to plant origin, environmental conditions, phenological stage, and the polarity of the extraction solvents; (iii) to present the pharmacological properties in agreement with the traditional uses of this plant; and (iv) to demonstrate the correlation between the chemical profile and the pharmacological effect. Various compositions were observed, including phenolic acids, flavonoid glycosides, anthocyanins, catechins, and their derivatives. The biological and therapeutic potentials of lentisk extracts have been evaluated in terms of antioxidant, antimicrobial, and anti-inflammatory activities. Most of these activities are related to the phenolic composition of this plant. The content of this review will undoubtedly contribute to the choice of techniques for isolating the different bioactive molecules contained in the P. lentiscus. It is also of significance for the potential development of a micro-industrial sector based on the valorization of lentisk polyphenols.
Collapse
Affiliation(s)
- Chabha Sehaki
- BIOPI-UPJV Laboratory UMRT BioEcoAgro INRAE1158, SFR Condorcet FR CNRS 3417, UFR of Sciences, University of Picardie Jules Verne, 33 Rue Saint Leu, 80000 Amiens, France
- Laboratory of Natural Resources, University Mouloud Mammeri of Tizi-Ouzou, Tizi Ouzou 15000, Algeria
| | - Nathalie Jullian
- BIOPI-UPJV Laboratory UMRT BioEcoAgro INRAE1158, SFR Condorcet FR CNRS 3417, UFR of Sciences, University of Picardie Jules Verne, 33 Rue Saint Leu, 80000 Amiens, France
| | - Fadila Ayati
- Laboratory of Natural Resources, University Mouloud Mammeri of Tizi-Ouzou, Tizi Ouzou 15000, Algeria
| | - Farida Fernane
- Laboratory of Natural Resources, University Mouloud Mammeri of Tizi-Ouzou, Tizi Ouzou 15000, Algeria
| | - Eric Gontier
- BIOPI-UPJV Laboratory UMRT BioEcoAgro INRAE1158, SFR Condorcet FR CNRS 3417, UFR of Sciences, University of Picardie Jules Verne, 33 Rue Saint Leu, 80000 Amiens, France
| |
Collapse
|
2
|
Vlastos D, Drosopoulou E, Efthimiou I, Gavriilidis M, Panagaki D, Mpatziou K, Kalamara P, Mademtzoglou D, Mavragani-Tsipidou P. Genotoxic and Antigenotoxic Assessment of Chios Mastic Oil by the In Vitro Micronucleus Test on Human Lymphocytes and the In Vivo Wing Somatic Test on Drosophila. PLoS One 2015; 10:e0130498. [PMID: 26110900 PMCID: PMC4482422 DOI: 10.1371/journal.pone.0130498] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2015] [Accepted: 05/19/2015] [Indexed: 12/16/2022] Open
Abstract
Chios mastic oil (CMO), the essential oil derived from Pistacia lentiscus (L.) var. chia (Duham), has generated considerable interest because of its antimicrobial, anticancer, antioxidant and other beneficial properties. In the present study, the potential genotoxic activity of CMO as well as its antigenotoxic properties against the mutagenic agent mitomycin-C (MMC) were evaluated by employing the in vitro Cytokinesis Block MicroNucleus (CBMN) assay and the in vivo Somatic Mutation And Recombination Test (SMART). In the in vitro experiments, lymphocytes were treated with 0.01, 0.05 and 0.10% (v/v) of CMO with or without 0.05 μg/ml MMC, while in the in vivo assay Drosophila larvae were fed with 0.05, 0.10, 0.50 and 1.00% (v/v) of CMO with or without 2.50 μg/ml MMC. CMO did not significantly increase the frequency of micronuclei (MN) or total wing spots, indicating lack of mutagenic or recombinogenic activity. However, the in vitro analysis suggested cytotoxic activity of CMO. The simultaneous administration of MMC with CMO did not alter considerably the frequencies of MMC-induced MN and wing spots showing that CMO doesn't exert antigenotoxic or antirecombinogenic action. Therefore, CMO could be considered as a safe product in terms of genotoxic potential. Even though it could not afford any protection against DNA damage, at least under our experimental conditions, its cytotoxic potential could be of interest.
Collapse
Affiliation(s)
- Dimitris Vlastos
- Department of Environmental and Natural Resources Management, University of Patras, Agrinio, Greece
| | - Elena Drosopoulou
- Department of Genetics, Development and Molecular Biology, School of Biology, Faculty of Science, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Ioanna Efthimiou
- Department of Environmental and Natural Resources Management, University of Patras, Agrinio, Greece
| | - Maximos Gavriilidis
- Department of Genetics, Development and Molecular Biology, School of Biology, Faculty of Science, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Dimitra Panagaki
- Department of Genetics, Development and Molecular Biology, School of Biology, Faculty of Science, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Krystalenia Mpatziou
- Department of Genetics, Development and Molecular Biology, School of Biology, Faculty of Science, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Paraskevi Kalamara
- Department of Genetics, Development and Molecular Biology, School of Biology, Faculty of Science, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Despoina Mademtzoglou
- Department of Genetics, Development and Molecular Biology, School of Biology, Faculty of Science, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Penelope Mavragani-Tsipidou
- Department of Genetics, Development and Molecular Biology, School of Biology, Faculty of Science, Aristotle University of Thessaloniki, Thessaloniki, Greece
| |
Collapse
|
3
|
Vlastos D, Mademtzoglou D, Drosopoulou E, Efthimiou I, Chartomatsidou T, Pandelidou C, Astyrakaki M, Chalatsi E, Mavragani-Tsipidou P. Evaluation of the genotoxic and antigenotoxic effects of Chios mastic water by the in vitro micronucleus test on human lymphocytes and the in vivo wing somatic test on Drosophila. PLoS One 2013; 8:e69494. [PMID: 23936030 PMCID: PMC3720709 DOI: 10.1371/journal.pone.0069494] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2013] [Accepted: 06/10/2013] [Indexed: 12/31/2022] Open
Abstract
Chios mastic gum, a plant-derived product obtained by the Mediterranean bush Pistacia lentiscus (L.) var. chia (Duham), has generated considerable interest because of its antimicrobial, anticancer, antioxidant and other beneficial properties. Its aqueous extract, called Chios mastic water (CMW), contains the authentic mastic scent and all the water soluble components of mastic. In the present study, the potential genotoxic activity of CMW, as well as its antigenotoxic properties against the mutagenic agent mitomycin-C (MMC), was evaluated by employing the in vitro Cytokinesis Block MicroNucleus (CBMN) assay and the in vivo Somatic Mutation And Recombination Test (SMART). In the former assay, lymphocytes were treated with 1, 2 and 5% (v/v) of CMW with or without MMC at concentrations 0.05 and 0.50 µg/ml. No significant micronucleus induction was observed by CMW, while co-treatment with MMC led to a decrease of the MMC-induced micronuclei, which ranged between 22.8 and 44.7%. For SMART, larvae were treated with 50 and 100% (v/v) CMW with or without MMC at concentrations 1.00, 2.50 and 5.00 µg/ml. It was shown that CMW alone did not modify the spontaneous frequencies of spots indicating lack of genotoxic activity. Τhe simultaneous administration of MMC with 100% CMW led to considerable alterations of the frequencies of MMC-induced wing spots with the total mutant clones showing reduction between 53.5 and 74.4%. Our data clearly show a protective role of CMW against the MMC-induced genotoxicity and further research on the beneficial properties of this product is suggested.
Collapse
Affiliation(s)
- Dimitris Vlastos
- Department of Environmental and Natural Resources Management, University of Patras, Agrinio, Greece
| | | | | | | | | | | | | | | | | |
Collapse
|